Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 5Completed 5Withdrawn 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 590Neoplasms 499Prostatic Neoplasms 316Lung Neoplasms 239Colorectal Neoplasms 201Motor Activity 134Carcinoma, Non-Small-Cell Lung 116Uterine Cervical Neoplasms 114Pancreatic Neoplasms 109Brain Neoplasms 109Head and Neck Neoplasms 104Stomach Neoplasms 100Rectal Neoplasms 98Carcinoma, Hepatocellular 97Ovarian Neoplasms 86Colonic Neoplasms 86Neoplasm Metastasis 68Esophageal Neoplasms 67Multiple Myeloma 65Hematologic Neoplasms 62Urinary Bladder Neoplasms 60Melanoma 59Sarcoma 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 58Glioblastoma 58Endometrial Neoplasms 57Glioma 53Anxiety Disorders 51Lymphoma 50Gastrointestinal Neoplasms 49

Interventions

Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Recruiting × Lymphadenopathy × Clear all
NCT06527027 2025-12-30

LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes

Copernicus Memorial Hospital

Phase NA Recruiting
1,000 enrolled

Lymphadenopathy, Lymphatic Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡